Vertebral osteomyelitis is relatively uncommon and is frequently overlooked because it causes back pain, which can be triggered by a pulled muscle or spine injury, according to Elie F. Berbari, MD, lead author of the guidelines and associate chair of education for the division of infectious disease at Mayo Clinic College of Medicine in Rochester, Minn.
“Back pain is so common — and usually not caused by infection — that diagnosis often is missed or delayed,” said Dr. Berbari. “The infection causes severe pain that often wakes the person at night and does not go away after pain management or rest. If that’s the case, the doctor needs to start considering that something else is going on, especially if the patient has a fever.”
To address the often overlooked condition, an 11-member panel comprised of a variety of specialists — including infectious diseases physicians, an orthopedic surgeon and a radiologist — created the IDSA treatment guidelines.
According to an IDSA news release, the voluntary guidelines are not meant to replace a physician’s judgment, but rather to support the individualized decision-making process in each patient’s circumstances.
To read the full guidelines on vertebral osteomyelitis in the journal Clinical Infectious Diseases, click here.
More articles on infection control:
Single-use sharps containers linked to lower C. diff infection rates: 3 study findings
Consumer Reports rates hospitals on infections: 9 highest, 12 lowest performing hospitals
International infectious disease commission to hold first-ever meeting Wednesday
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
